A new study provides evidence from lab experiments that a drug already used in people to fight tapeworms might also prove effective against strains of the superbug MRSA, which kills thousands of ...
Scientists at a UA lab are putting the finishing touches on a new method to detect aggressive bacteria infections 95 percent faster, which could save hospitals around the nation hundreds of thousands ...
The US Food and Drug Administration (FDA) has approved a new, faster diagnostic test based on bacterial viability and a novel technology to detect methicillin-resistant Staphylococcus aureus (MRSA) ...
Easy-to-use molecular test offers faster results to help healthcare facilities control spread of methicillin-resistant Staphylococcus aureus (MRSA) "It is important that healthcare professionals have ...
The Food and Drug Administration (FDA) has authorized marketing of a new diagnostic test, cobas vivoDx MRSA (Roche Molecular Systems Inc), to detect methicillin-resistant Staphylococcus aureus (MRSA) ...
An infectious disease test developer has raised $1.9 million in a series B financing round to advance its MRSA screening panel. It will also use the funds to develop its new molecular diagnostic ...
Diagnostics company bioMerieux (PARIS:BIM) has received 510(k) clearance from the U.S. Food and Drug Administration for a test to detect and screen for methicillin-resistant staphylococcus, more ...
bioMérieux, French manufacturer of diagnostic solutions, has received FDA 510(k) approval for NucliSENS EasyQ MRSA, an automated molecular test for MRSA, according to a company news release. The test ...
Detect-Ready assay requires swab DNA and provides results in three hours. Molecular Detection (MDI) appointed Launch Diagnostics as the exclusive distributor for its Detect-Ready™ MRSA assay in the ...
The Illinois Department of Public Health announced the publication of the first infection surveillance data on Clostridium difficile and methicillin-resistant Staphylococcus aureus rates from lab ...
For the first time, Illinois hospitals have released data on the rates of Clostridium difficile and methicillin-resistant Staphylococcus aureus from lab results. This data is available on the Illinois ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results